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  The proliferation, migration, cytokine release, and contraction of airway smooth muscle cells are 
key events in the airway remodeling process that occur in lung disease such as asthma, chronic 
obstruction pulmonary disease, and cancer. These events can be modulated by a number of factors, 
including cigarette smoke extract (CSE). CSE-induced alterations in the viability, migration, and 
contractile abilities of normal human airway cells remain unclear. This study investigated the effect 
of CSE on cell viability, migration, tumor necrosis factor (TNF)-α secretion, and contraction in normal 
human bronchial smooth muscle cells (HBSMCs). Treatment of HBSMCs with 10% CSE induced cell 
death, and the death was accompanied by the generation of reactive oxygen species (ROS). CSE-induced 
cell death was reduced by N-acetyl-l-cysteine (NAC), an ROS scavenger. In addition, CSE reduced the 
migration ability of HBSMCs by 75%. The combination of NAC with CSE blocked the CSE-induced 
reduction of cell migration. However, CSE had no effect on TNF-α secretion and NF-κB activation. 
CSE induced an increase in intracellular Ca
2＋ concentration in 64% of HBSMCs. CSE reduced the 
contractile ability of HBSMCs, and the ability was enhanced by NAC treatment. These results 
demonstrate that CSE treatment induces cell death and reduces migration and contraction by 
increasing ROS generation in normal HBSMCs. These results suggest that CSE may induce airway 
change through cell death and reduction in migration and contraction of normal HBSMCs. 
Key Words: Bronchiole, Cell migration, Cigarette smoke extract, Reactive oxygen species, Smooth muscle
INTRODUCTION
  Cigarette smoke (CS) is well known to be a risk factor 
for lung diseases, including chronic obstructive pulmonary 
disease (COPD), lung cancer, and asthma [1,2]. These lung 
diseases are accompanied by airway inflammation, airway 
hyperresponsiveness, and airway remodeling [3].
  Airway remodeling is characterized by epithelial detach-
ment, subepithelial fibrosis, mucus hyperplasia, airway 
edema, and an increase in airway smooth muscle mass. 
Abnormalities in the proliferation, apoptosis, migration, cy-
tokine secretion, and contraction of smooth muscle cells 
play important roles in airway remodeling [4-6]. The cause 
of such abnormalities is complex and depends on a network 
of inflammatory mediators and cytokines [7]. These cyto-
kines play important roles in airway smooth muscle remod-
eling. CS induces significant increases in multiple cytokines 
including tumor necrosis factor (TNF)-α, which is central 
to many acute inflammatory cascades [8,9]. In addition to 
inflammatory cytokines, reactive oxygen species (ROS) gen-
eration is also a risk factor for the airway remodeling in 
lung diseases. CS is a potent source of ROS generation 
[10,11]. ROS mediates cell contraction in canine tracheal 
smooth muscle cells (SMCs) [12]. CS extract (CSE)-induced 
oxidant production induces the dysregulation of in-
flammatory processes [13]. Some of the chemical and oxidiz-
ing pollutants contained in CSE directly affect airway 
smooth muscle contractility [14,15]. The in vivo responsive-
ness of airways is augmented after CS exposure [16-18]. 
However, acute exposure to CSE leads to airway relaxation 
[19]. Smooth muscle contraction plays a fundamental role 
in regulating the functions of airways, and it could be medi-
ated by an increase in intracellular Ca
2＋ concentration 
([Ca
2＋]i) [20].
  CSE effect has been studied in a variety of cell types, 
such as pulmonary endothelial cell, lung fibroblasts, epi-398 CH Yoon, et al
thelial cells, and airway smooth muscle cells [21-24]. 
Relatively little is known concerning the effect of CSE on 
airway smooth muscle contractility compared to the CSE 
effect on inflammation, oxidative stress, and airway hyper-
responsiveness. In addition, the effects of CSE on increase 
in airway smooth muscle mass in lung diseases are estab-
lished, but little is known about the effect of CSE on the 
increase in mass and contractility of normal airway smooth 
muscle. Human bronchial (airway) smooth muscle cells 
(HBSMCs) are well-suited for studying CSE-induced cell 
contractility and hypertrophy in airway remodeling. This 
study was performed to identify whether CSE changes air-
way remodeling-related processes, such as cell viability, mi-
gration, contraction, TNF-α release, or [Ca
2＋]i in normal 
HBSMCs. We found that CSE induced cell death and re-
duced cell migration and contraction but it had no effect 
on TNF-α release and NF-κB activation.
METHODS
Chemicals
  All of the chemicals used in this study were purchased 
from Sigma (St. Louis, MO, USA) unless otherwise 
specified. The stock solution of N-acetyl-l-cysteine (NAC, 
500 mM) and ethylene glycol tetraacetic acid (EGTA, 50 
mM) was prepared in distilled water. Nicotine (100 mM) 
and 1,2-Bis (2-aminophenoxy) ethane-N,N,N',N'-tetraacetic 
acid tetrakis-acetoxymethyl ester (BAPTA-AM, 10 mM) 
were dissolved in ethanol and dimethyl sulfoxide (DMSO), 
respectively. The stock solutions of chemicals were diluted 
in culture medium to a working concentration. When etha-
nol or DMSO was used as a solvent, a solution containing 
an equivalent concentration was used as a control.
Preparation of CSE
  CSE was prepared using a previously published method 
[22]. To produce 100% CSE, one unfiltered Camel cigarette 
(R.J. Reynolds, Winston-Salem, NC, USA) was passed 
through 10 ml of phosphate-buffered saline (PBS) using a 
vacuum pump. The 100% CSE solution was adjusted to a 
pH of 7.4 and filtered through a 0.2-μm-pore filter 
(Minisart
Ⓡ, Sartorius, Goettingen, Germany) to remove 
particles and bacteria. The CSE was diluted to the appro-
priate concentration and was added to HBSMCs within 10 
min of preparation.
Cell culture
  Normal HBSMCs were purchased from PromoCell GmbH 
(Heidelberg, Germany). The HBSMCs were cultured in 
smooth muscle cell basal medium supplemented with 0.5 
ng/ml epidermal growth factor, 2 ng/ml basic fibroblast 
growth factor, 5μg/ml insulin, 5% fetal calf serum, 50μg/ 
ml amphotericin B, and 50 ng/ml gentamycin based on the 
manufacturer’s recommendations (PromoCell). Cells were 
incubated at 37
oC in humidified air containing 5% CO2. The 
medium was replaced every two days.
Cell viability assay
  Cell viability was determined colorimetrically using the 
3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bro-
mide (MTT) reagent (Duchefa, Haarlem, Netherlands). 
Cells at the exponential phase were seeded (4×10
4 cells/ml) 
in a 24-well plate. After 24 h of extract or chemical treat-
ment, 20μl of 5 mg/ml MTT solution was added to each 
well (0.1 mg/ml) and incubated for 4 h. The supernatants 
were aspirated, the formazan crystals in each well were dis-
solved in 200μl DMSO for 30 min at 37
oC, and the 24-well 
plates were read at 570 nm with a microplate reader 
(Bio-Rad, Hercules, CA, USA).
Measurement of ROS generation
  The HBSMCs were cultured with or without 3 mM NAC 
while exposed to 10% CSE for 4 h. The HBSMCs were load-
ed with 5μM of dichlorodihydrofluorescein diacetate 
(H2DCFDA, Calbiochem, San Diego, CA, USA) for 30 min 
in the dark. After incubation, the cells were washed three 
times with PBS and immediately analyzed for fluorescence 
intensity using a confocal laser scanning microscope equip-
ped with a fluorescence system (IX70 Fluoview, Olympus, 
Tokyo, Japan). For the detection of green fluorescence 
(H2DCFDA), cells were illuminated with 488- and 519-nm 
laser lines. The fluorescent images were saved in the tagged 
image file format and analyzed using the Fluoview software 
program (version 2.0, Olympus).
Migration assay
  For the two-dimensional (2-D) migration assay, cells were 
seeded in a μ-dish (ibidi GmbH, Munich, Germany) at a 
density of 1×10
6 cells/ml and treated with 8μg/ml mitomy-
cin C in culture media for 2 h to eliminate proliferation. 
Photomicrographs were taken after incubation. Relative 
cell migration distance (closure) was determined by meas-
uring the gap width on the monolayer under 10× magnifica-
tion (Axiovert 40C, Carlzeiss MicroImaging, Göttingen, 
Germany) and by subtracting this value from the initial 
value (i.e., the initial width at 0 h). The transwell (three-di-
mension, 3-D) migration assay was performed using the 
CytoSelect
TM Cell Migration Assay Kit containing poly-
carbonate membrane inserts (8-μm-pore membrane; Cell 
Biolabs, San Diego, CA, USA) according to the manu-
facturer’s instructions. A cell suspension containing 1×10
5 
cells/ml in serum-free medium was prepared, and 300μl 
of the cell suspension was added to the upper chamber of 
each insert. The lower chamber contained medium with 
10% FBS to allow cell migration toward the lower face of 
the transwell culture inserts. Cells were incubated for 12 
h at 37
oC in a 95% air-5% CO2 gas mixture. Non-migrating 
cells on the inner side of the transwell culture inserts were 
gently removed with a cotton-tipped swab. Migrated cells 
remaining on the bottom surface were stained with a 
cell-staining solution (1% methylene blue) for 40 min at 
room temperature. Photomicrographs of five individual 
fields per insert were taken using a microscope (Axiovert 
40C), and cells were enumerated to calculate the average 
number of cells that had migrated. The stained insert was 
washed thoroughly and dissolved by incubating for 10 min 
with extraction solution (1% Triton X-100). Each sample 
was transferred to a 96-well microtiter plate, and the ab-
sorbance at 560 nm was measured using a plate reader 
(Infinite
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Fig. 1. CSE-induced cell death in HBSMCs. (A) The effect of CSE 
on HBSMC viability. HBSMCs were exposed to 0 to 30% CSE for 
24 h. (B) CSE-induced ROS generation in HBSMCs. Representative 
photomicrographs of HBSMCs labeled with H2DCFDA to evaluate 
ROS generation (left panel, fluorescent image; right panel, phase 
contrast). The ROS levels in the cells were quantified by fluore-
scence microscopy after 4 h of CSE treatment. NAC was pretreated 
1 h before CSE treatment. The 10% CSE and 3 mM NAC were 
applied to HBSMCs. The scale bar represents 100μm. (C) The 
effect of NAC on HBSMC viability. HBSMCs were exposed to 10% 
CSE and/or NAC (3 mM) for 24 h. Each bar is the mean±SD of 
five independent experiments. The plus and minus signs (+ and −)
represent conditions with and without each treatment, respectively. 
*p＜0.05 compared with the corresponding control (0% or −/−), 
†p<0.05 compared with the CSE treatment.
Measurement of intracellular Ca
2＋ changes
  The changes in [Ca
2＋]i was measured using the Ca
2＋- 
sensitive fluorescent indicator fluo 3-AM (Molecular probe, 
Eugene, Oregon, USA) and a confocal laser scanning micro-
scope (IX70 Fluoview). The HBSMCs were incubated with 
5μM fluo 3-AM in a coverglass-bottom dish (SPL, Pocheon, 
South Korea) for 45 min and washed three times with se-
rum-free medium. Fluorescent images were scanned every 
5 sec at 488 nm with an excitation argon laser and 530 
nm longpass emission filter. All scanned images were proc-
essed to analyze changes in [Ca
2＋]i at the single-cell level. 
Cell contraction assay
  The contraction assay was performed using a cell con-
traction assay kit (Cell Biolabs). Briefly, HBSMCs (5×10
5 
cells/ml) were cultured for 2 days; the cultured HBSMCs 
were resuspended in culture media; and the cell suspension 
was mixed with collagen gel solution (bovine Type I). The 
cell-collagen mixture was placed in a 24-well plate and in-
cubated for 1 h at 37
oC. After collagen polymerization, cul-
ture medium without the growth factor supplement was 
added onto the collagen gel lattice. Cells in collagen gels 
were allowed to equilibrate for 2 days, the gels were re-
leased from the culture plate, and various agents were add-
ed to the media 1 h prior to release. The control for CSE 
and NAC was serum free media, and the control for 2, 3-bu-
tanedione monoxime (BDM) was 0.1% DMSO in medium. 
BDM was used as a contraction inhibitor (negative control). 
Images of the gels were captured with a camera (Canon, 
Tokyo, Japan), and the gel size change was measured at 
the indicated times with a ruler and quantified with image 
analysis software (Fluoview software program, Olympus). 
For each condition, collagen contraction was determined in 
at least quadruplicate.
Measurement of TNF-α concentration
  The HBSMCs were treated with 10% CSE for 24 h in 
the presence or absence of NAC in 96-well plates. The cell 
culture media was collected and stored at −20
oC prior to 
the analysis. The amounts of secreted TNF-α in the media 
were measured using TNF-α  ELISA kits (BioSource; 
Camarillo, CA, USA) according to the manufacturer's 
instructions.
Western blot analysis
  The HBSMCs were homogenized in a protein extraction 
solution (PRO-PREP
TM, iNtRON Biotechnology Inc, Seong-
nam, Korea) containing 50 mM Tris-Cl (pH 7.5), 150 mM 
NaCl, 1 mM dithiothreitol (DTT), 0.5% nonyl phenox-
ylpolyethoxylethanol (NP-40), 1% Triton X-100, 1% deoxy-
cholate, 0.1% sodium dodecyl sulfate (SDS), 1 mM ethyl-
enediaminetetraacetic acid (EDTA), 1μM leupeptin, 1μM 
pepstatin A, 1 mM phenylmethylsulfonyl fluoride (PMSF), 
and 0.1μM aprotinin. After the addition of the protein ex-
traction solution, the cells were incubated for 30 min on 
ice with intermittent vortexing. The extracts were clarified 
by centrifugation at 13,000 rpm (16,609×g; Micro 17TR, 
Hanil, Korea) for 20 min at 4
oC. The resulting supernatant 
was separated with 8% SDS-polyacrylamide gel and trans-
ferred to PVDF membrane for 15 min using a semi-dry 
transfer (Bio-Rad, CA, USA). The membranes were blocked 
with 5% fat-free dry milk and then incubated with NF-κB 
p65 polyclonal (1：1,000 dilution) (Cell Signaling, Danvers, 
MA, USA), Phospho-NF-κB p65 (Ser536) rabbit mono-
clonal (Cell Signaling, 1：1,000 dilution), and α-tubulin 
monoclonal antibodies (1：10,000 dilution). The primary 
antibody incubation was followed by incubation with a sec-
ondary peroxidase-conjugated anti-rabbit or anti-mouse an-
tibody at 1：10,000. Immuno-positive bands were vi-
sualized by enhanced chemiluminescence (ECL Plus kit, 
ELPIS, Taejon, Korea) following the manufacturer’s in-
structions.
Statistics
  A one-way ANOVA (SPSS18, Chicago, IL, USA) was used 
with p＜0.05 as the threshold for significance. Data are rep-
resented as mean±SD.
RESULTS
Effect of CSE on cell proliferation and migration in 
normal HBSMCs
  The cytotoxicity of CSE was examined in HBSMCs using 
an MTT assay. The HBSMCs were cultured in the presence 
of various concentrations of CSE (0.01∼30%). When the 
cells were treated with CSE for 24 h, the cell viability sig-400 CH Yoon, et al
Fig. 2. CSE-induced reduction of cell migration. (A) Migration 
ability of HBSMCs by CSE treatment. Phase-contrast images of 
wound areas at 0, 6, 12, and 24 h after 10% CSE treatment. (B) 
Representative microscopic images of migrating cells by 3-D 
migration assays. HBSMCs were seeded onto the transwell culture 
inserts and incubated at 37
oC for 12 h. Migrated cells remaining 
on the bottom surface were stained with 1% methylene blue. (C) 
Summary of effect of CSE on migration ability of HBSMCs. Each 
bar is the mean±SD of five independent experiments. The scale bar 
represents 100μm. *p＜0.05 compared with the control (−/−), 
†p
＜0.05 compared with the CSE treatment.
Fig. 3. Effect of CSE on TNF-α secretion and NF-κB activation 
in HBSMCs. (A) TNF-α concentration secreted from HBSMCs by 
CSE treatment. HBSMCs were treated with 10% CSE and/or 3 mM 
NAC for 24 h. Nicotine (10μM) effect was compared with the 
control. The supernatants were collected and measured using a 
TNF-α ELISA kit. Each bar is the mean±SD of seven independent 
experiments. (B) No effect of CSE on NF-κB activation. HBSMCs 
were treated with CSE (10%) or nicotine (10μM) for 24 h. Total 
protein was extracted and subjected to western blot analysis using 
anti-NF-κB and anti-phospho-NF-κB antibodies. Lipopolysacar-
ride was used as a positive control for NF-κB activation [25]. The 
time of chemiluminescent reaction was controlled to show strong 
signals.
nificantly decreased by approximately 38% in the 10% CSE 
treatment compared with the control (Fig. 1A). As shown 
in Fig. 1B, ROS was detected using H2DCFDA that has 
been widely used as a detector of ROS in many kinds of 
cells. The dye becomes fluorescent after cellular oxidation. 
CSE significantly increased ROS levels by 2.5-fold com-
pared with the control (p＜0.05, n=5). CSE-induced ROS 
generation was attenuated by pretreatment for 1 h with 
3 mM NAC. The CSE-induced cell death was also reduced 
by NAC treatment (Fig. 1C).
  To test the migration ability of HBSMC, the cells were 
incubated in a μ-dish (ibidi GmbH). However, the 10% CSE 
treatment reduced cell migration ability by 57% compared 
with the control (Fig. 2A). The cells’ migration ability was 
determined using a 3-D migration assay. The 3-D migration 
assay revealed that CSE treatment significantly inhibited 
cell migration (p＜0.05, Fig. 2B), reducing migration by 
75% in the CSE treatment (Fig. 2C). The combination of 
NAC and CSE offset the CSE-induced reduction in cell mi-
gration (Fig. 2C). NAC alone also enhanced cell migration, 
suggesting that regulation of ROS concentration might play 
a role in migration of HBSMCs. NAC treatment may reduce 
endogenous ROS generation in HBSMCs.
Effect of CSE on inflammatory cytokine release and 
NF-κB activation
  The TNF-α concentration was analyzed in the super-
natants obtained after CSE treatment of HBSMCs. CSE 
had no significant effect on TNF-α concentration compared 
with that in the control (Fig. 3A, 15.9±3.4 pg/ml in CSE 
versus 19.5±8.4 pg/ml in control), and CSE (10%) failed to 
induce NF-κB activation (Fig. 3B). Nicotine (10μM), a ma-
jor component of CSE, also failed to increase TNF-α con-
centration and NF-κB activation (Fig. 3). CSE (0.01∼1%) 
reduced NF-κB activation compared with the control (data 
not shown).
Effect of CSE on intracellular Ca
2＋ changes and cell 
contraction
  To identify CSE-induced changes in [Ca
2＋]i, a calcium im-
age analysis was performed. The addition of 10% CSE to 
the normal physiological solution transiently increased [Ca
2＋]i 
in the HBSMCs. The application of the 10% CSE produced 
different patterns of transient Ca
2＋ spikes in the HBSMCs 
(Fig. 4A). The 10% CSE treatment induced a low repetitive 
Ca
2＋ spike in some HBSMCs while some cells showed a 
high Ca
2＋ spike with or without a plateau in response to 
CSE treatment. These Ca
2＋ responses were observed in 128 
of 200 HBSMCs. However, the rest of the cells (72 of 200, 
34.6±11.3%) did not produce Ca
2＋ peaks or showed reduc-
tion in response to 10% CSE (Fig. 4A). The combined treat-
ment with both CSE and NAC did not show significant in-
crease in the levels of intracellular Ca
2＋ (CSE: 1.6±1.4 in 
200 of 200; CSE+NAC: 2.1±1.1 in 66 of 66, Fig. 4B). The 
combined treatment with CSE and NAC also showed sim-
ilar patterns of transient Ca
2＋ spike to CSE treatment 
(data not shown). As shown in Fig. 4A, the changes in [Ca
2＋]i 
were represented as fluorescence intensity (F), and the F 
was normalized to basal F before CSE treatment (F/F0). 
The net changes in F shown in Fig. 4B were calculated with 
subtraction of F0 from the maximum level of F showing 
after the addition of 10% CSE divided by F0 ((Fmax-F0)/ Effect of CSE on Contraction of HBSMCs 401
Fig. 4. Effect of CSE on intracellular Ca
2＋ increase and cell 
contraction. (A) CSE-induced Ca
2＋ wave patterns in HBSMCs. CSE 
(10%) was applied to the bath medium. Arrowheads indicate the 
addition of CSE and/or NAC. (B) Effect of NAC on the CSE-induced 
Ca
2＋ increase. The net change in Ca
2＋ levels was normalized to 
F0 (Fmax-F0/F0), and the data obtained from all cells were 
averaged. Fmax and F0 represent the maximum fluorescence level 
and initial fluorescence intensity of a cell. (C) Representative 
photographs of collagen matrices in a collagen gel contraction 
assay. Cells were exposed to control medium or medium containing 
10% CSE for 24 h. N/C represents negative control containing BDM 
(a contraction inhibitor). ACh represents acetylcholine, which was 
used as a positive control. (D) Summary of the evaluation of assay 
results of cell contraction. Each bar is the mean±SD of five 
independent experiments. *p＜0.05 compared with the control, 
†p
＜0.05 compared with the CSE treatment.
F0). The data shown in Fig. 4B were obtained from average 
of all data tested in this study.
  Cell contraction is a result of cell proliferation, migration, 
Ca
2＋ c h a n g e s ,  o r  c y t o k i n e  r e l e a s e .  T o  t e s t  w h e t h e r  C S E  
modulates the contractility of HBSMCs, a gel contraction 
assay was performed. The addition of 10% CSE to the 
HBSMC gels reduced contractility by 32% compared with 
the control (Fig. 4C), and the area of the treated gels was 
larger than that of the control gels (Fig. 4D). However, the 
treatment combination of CSE with NAC increased con-
traction compared with the cells treated only with CSE 
(Fig. 4C and D). The results of combined treatment with 
both CSE and Ca
2＋ chelator (EGTA or BAPTA) could not 
be clearly analyzed because the gel’s properties were trans-
formed (e.g. gel is torn easily) (data not shown).
DISCUSSION
  I n  t h i s  s t u d y ,  C S E  s h o w e d  a n  i n h i b i t o r y  e f f e c t  o n  c e l l  
proliferation, migration, and contraction of normal HBSMCs. 
However, we could not find a direct effect of CSE on TNF-α 
secretion or on the NF-κB activation of HBSMCs. Numer-
ous studies have reported that CSE has a deleterious effect 
on cellular proliferation, migration, and contraction, and 
thus, CSE induces lung diseases, such as COPD, lung can-
cer, and asthma. Cell proliferation is required for airway 
remodeling, which includes hypertrophy and hyperplasia. 
However, in both our previous and this current study, CSE 
induced cell death through ROS generation in HBSMCs 
[11]. Control of ROS generation could be a factor for regu-
lation of cell proliferation [26]. Studies in the CSE’s effect 
on cell proliferation show varying results. Some researchers 
have reported that CSE promotes the cell proliferation of 
bovine tracheal SMCs [27] and human aortic SMCs [28]. 
However, other researchers have reported that CSE in-
duces apoptosis of human airway SMCs [29,30] and human 
pulmonary endothelial cells [22], which is consistent with 
our results. These different results are likely due to use 
of different cell types, CSE isolation methods, and CSE 
components.
  CS is a mixture of more than 4,000 different compounds 
that include significant amounts of free radicals, toxins, 
and electrophiles [2,28]. The components differ depending 
on the isolation methods, producing smoke particles that 
are heptane-, water-, or DMSO-soluble. Of the many chem-
icals in CSE, nicotine is one of the most active pharmaco-
logical compounds. Nicotine has anti-inflammatory effects 
in ulcerative colitis and has been shown to decrease the 
release of interleukin 1β and TNF-α in alveolar macro-
phages [31-34]. In addition, nicotine promotes vascular 
SMC migration [35]. The components of CSE, including nic-
otine, can induce changes such cell proliferation, cell migra-
tion, TNF-α secretion, and contraction in many types of 
cells. Heptane- and DMSO-soluble smoke particles, but not 
water-soluble smoke particles, enhanced contractile re-
sponses in vasculature and airway [28]. However, chronic 
treatment of bovine tracheal smooth muscle strips with 
CSE decreased maximal methacholine- and KCl-induced 
contraction [27]. In contrast, acute exposure to CSE leads 
to airway relaxation in mice, which is partially mediated 
by nicotine [19].
  CSE increases TNF-α expression and secretion in hu-
man keratinocytes [8] and mouse middle ear cells [9]. Many 
studies indicate that CSE induces changes in TNF-α ex-
pression [36,37], but there are no direct reports from bron-
chial SMCs. In contrast, CSE inhibited nuclear factor kap-
pa B (NF-κB) expression in human airway SMCs [28]. NF-
κB is a key molecule for the induction of TNF-α. Other 
studies reported that CSE induced nuclear transcription of 
NF-κB and COX-2 genes in human tracheal SMCs [38, 39]. 
In our study, CSE (10%) had no effect on TNF-α release 
and NF-κB activation. Low levels (0.01∼1%) of CSE de-
creased NF-κB activation. The decrease in or the absence 
of change in TNF-α secretion and NF-κB activation in 
HBSMC could be resulted from anti-inflammatory effect of 
the nicotine in the CSE.
  C h a n g e s  i n  [ C a
2＋]i are responsible for the enhanced bron-
chial smooth muscle contraction induced by CSE [40]. CSE 
mobilized Ca
2＋ in cultured guinea pig jugular ganglia neu-
rons and promoted contraction of isolated guinea pig bron-
chi [41]. In this study, however, not all HBSMCs exhibited 
CSE-induced Ca
2＋ increases. CSE even decreased the Ca
2＋ 
response in some cells. All cells did not respond to any 
treatments [42,43] because of differences in cell condition 
and cycles. The collagen gel contraction assay used in this 
study has been used to study the cell-mediated reorganiza-
tion of the extracellular matrix and the contraction exerted 
collectively by a population of cells [44,45]. The contraction 
of cells showing a CSE-induced Ca
2＋ increase might be a 
compensation for the cell that show a CSE-induced Ca
2＋ 
decrease or no response. However, we cannot exactly ex-
plain the relationship between CSE and Ca
2＋ changes in 
the cell contraction because of gel’s properties transformed 
by Ca
2＋ chelators. The inhibitory effect of CSE on con-
traction could be a result of cell death or a reduction in 402 CH Yoon, et al
migration by the HBSMCs. CSE-induced cell death could 
affect cell migration, and the altered cell migration could 
affect cell contraction.
  Our study found that CSE induced cell death and reduced 
cell migration and contraction via ROS generation. The 
combination of NAC with CSE blocked the CSE-induced 
changes in cell viability, migration, and contraction. CSE 
induced high ROS generation in HBSMCs. The control of 
ROS generation could be a key factor in CSE-induced air-
way remodeling. Our results suggest that CSE may induce 
airway change through cell death and reduction in migra-
tion and contraction of normal HBSMCs. Further studies 
will be needed to analyze the components of CSE extracted 
from different cigarettes to identify the molecular mecha-
nism by which CSE affects cell proliferation, migration, 
TNF-α secretion, and contraction.
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